Recovery after short-term bilirubin exposure in human NT2-N neurons

Brain Research

Volumn 1103, Issue 1, 2006, Pages 56-64

  Hankø, Erik ^a,b   Hansen, Thor Willy Ruud ^b,c   Almaas, Runar ^c,d   Rootwelt, Terje ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d NONE   (Norway)

Author keywords

Apoptosis; Bilirubin; Caspases; Cell death; Excitotoxicity; Functional recovery

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BILIRUBIN; CASPASE 3 INHIBITOR; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITROBLUE TETRAZOLIUM;

APOPTOSIS; ARTICLE; CELL ASSAY; CELL DEATH; CELL NUCLEUS MEMBRANE; CELL ULTRASTRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CONVALESCENCE; CULTURE MEDIUM; DELAYED NEUROTOXICITY; ENZYME ANALYSIS; EXCITOTOXICITY; HUMAN; HUMAN CELL; INCUBATION TIME; NERVE CELL CULTURE; NEUROPROTECTION; PRIORITY JOURNAL;

APOPTOSIS; BILIRUBIN; CASPASES; CELL DEATH; CELL LINE; CELL NUCLEUS; CULTURE MEDIA, SERUM-FREE; DIZOCILPINE MALEATE; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; FLUORESCENT DYES; HUMANS; NEURONS; RECEPTORS, N-METHYL-D-ASPARTATE; TETRAZOLIUM SALTS; THIAZOLES;

EID: 33746085237     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.05.083     Document Type: Article

References (53)

1. Almaas R., Saugstad O.D., Pleasure D., and Rootwelt T. Effect of barbiturates on hydroxyl radicals, lipid peroxidation, and hypoxic cell death in human NT2-N neurons. Anesthesiology 92 (2000) 764-774
2. Almaas R., Pytte M., Lindstad J.K., Wright M., Saugstad O.D., Pleasure D., and Rootwelt T. Acidosis has opposite effects on neuronal survival during hypoxia and reoxygenation. J. Neurochem. 84 (2003) 1018-1027
3. Amit Y., Poznansky M.J., and Schiff D. Bilirubin toxicity in a neuro-blastoma cell-line N-115: 2. Delayed-effects and recovery. Pediatr. Res. 25 (1989) 369-372
4. Batistatou A., Merry D.E., Korsmeyer S.J., and Greene L.A. Bcl-2 affects survival but not neuronal differentiation of Pc12 cells. J. Neurosci. 13 (1993) 4422-4428
5. Bernas T., and Dobrucki J.W. The role of plasma membrane in bioreduction of two tetrazolium salts, MTT, and CTC. Arch. Biochem. Biophys. 380 (2000) 108-116
6. Berridge M.V., Herst P.M., and Tan A.S. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol. Annu. Rev. 11 (2005) 127-152
7. Bratlid D. How bilirubin gets into the brain. Clin. Perinatol. 17 (1990) 449-465
8. Brodersen R. Bilirubin-solubility and interaction with albumin and phospholipid. J. Biol. Chem. 254 (1979) 2364-2369
9. Cowger M.L. Mechanism of bilirubin toxicity on tissue culture cells-factors that affect toxicity, reversibility by albumin, and comparison with other respiratory poisons and surfactants. Biochem. Med. 5 (1971) 1
10. Daugas E., Susin S.A., Zamzami N., Ferri K.F., Irinopoulou T., Larochette N., Prevost M.C., Leber B., Andrews D., Penninger J., and Kroemer G. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J. 14 (2000) 729-739
11. Degterev A., Boyce M., and Yuan J.Y. A decade of caspases. Oncogene 22 (2003) 8543-8567
12. Deshmukh M., and Johnson E.M. Programmed cell death in neurons: focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons. Mol. Pharmacol. 51 (1997) 897-906
13. Devries L.S., Lary S., and Dubowitz L.M.S. Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk low-birth-weight infants. Pediatrics 76 (1985) 351-354
14. Earnshaw W.C., Martins L.M., and Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68 (1999) 383-424
15. Eriksen E.F., Danielsen H., and Brodersen R. Bilirubin-liposome interaction-binding of bilirubin dianion, protonization, and aggregation of bilirubin acid. J. Biol. Chem. 256 (1981) 4269-4274
16. Gartner L.M. Neonatal jaundice. Pediatr. Rev. 15 (1994) 422-432
17. Grimmer I., Berger-Jones K., Buhrer C., Brandl U., and Obladen M. Late neurological sequelae of non-hemolytic hyperbilirubinemia of healthy term neonates. Acta Paediatr. 88 (1999) 661-663
18. Grojean S., Koziel V., Vert P., and Daval J.L. Bilirubin induces apoptosis via activation of NMDA receptors in developing rat brain neurons. Exp. Neurol. 166 (2000) 334-341
19. Hamabe W., Fukushima N., Yoshida A., and Ueda H. Serum-free induced neuronal apoptosis-like cell death is independent of caspase activity. Mol. Brain Res. 78 (2000) 186-191
20. Hanko E., Hansen T.W.R., Almaas R., Lindstad J., and Rootwelt T. Bilirubin induces apoptosis and necrosis in human NT2-N neurons. Pediatr. Res. 57 (2005) 179-184
21. Hanko E., Hansen T.W.R., Almaas R., Paulsen R., and Rootwelt T. Synergistic protection of a general caspase inhibitor and MK-801 in bilirubin-induced cell death in human NT2-N neurons. Pediatr. Res. 59 (2006) 72-77
22. Hoffman D.J., Zanelli S.A., Kubin J., Mishra O.P., and DelivoriaPapadopoulos M. The in vivo effect of bilirubin on the N-methyl-d-aspartate receptor/ion channel complex in the brains of newborn piglets. Pediatr. Res. 40 (1996) 804-808
23. Kaal E.C.A., Veldman H., Sodaar P., Joosten E.A.J., and Bar P.R.D. Oxidant treatment causes a dose-dependent phenotype of apoptosis in cultured motoneurons. J. Neurosci. Res. 54 (1998) 778-786
24. Kariya S., Takahashi N., Ooba N., Kawahara M., Nakayama H., and Ueno S. Humanin inhibits cell death of serum-deprived PCI2h cells. NeuroReport 13 (2002) 903-907
25. Liu Y.B., Peterson D.A., Kimura H., and Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69 (1997) 581-593
26. Lobner D. Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?. J. Neurosci. Methods 96 (2000) 147-152
27. Maisels M.J. Jaundice. In: Avery G.B., Fletcher M.A., and MacDonald M.G. (Eds). Neonatology, Pathophysiology and Management of the Newborn (1999), Lippincott Williams and Wilkins, Philadelphia 765-820
28. Maisels M.J., and Newman T.B. Bilirubin and neurological dysfunction-do we need to change what we are doing?. Pediatr. Res. 50 (2001) 677-678
29. Mayor F., Diezguerra J., Valdivieso F., and Mayor F. Effect of bilirubin on the membrane-potential of rat-brain synaptosomes. J. Neurochem. 47 (1986) 363-369
30. McDonald J.W., Shapiro S.M., Silverstein F.S., and Johnston M.V. Role of glutamate receptor-mediated excitotoxicity in bilirubin-induced brain injury in the Gunn rat model. Exp. Neurol. 150 (1998) 21-29
31. Meisel P., Jährig D., and Jährig K. Bilirubin im Liquor cerebrospinalis Neugeborener: I. Vergleichende Untersuchungen des Liquor cerebrospinalis. Kinderärztl. Prax. 49 (1981) 633-642
32. Nwaesei C.G., Vanaerde J., Boyden M., and Perlman M. Changes in auditory brain-stem responses in hyperbilirubinemic infants before and after exchange-transfusion. Pediatrics 74 (1984) 800-803
33. Ozmert E., Erdem G., Topcu M., Yurdakok M., Tekinalp G., Genc D., and Renda Y. Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants. Acta Paediatr. 85 (1996) 1440-1444
34. Paludetto R., Mansi G., Raimondi F., Romano A., Crivaro V., Bussi M., and D'Ambrosio G. Moderate hyperbilirubinemia induces a transient alteration of neonatal behavior. Pediatrics 110 (2002)
35. Patel A.J., Gunasekera S., Jen A., and deSilva H.A.R. beta-Amyloid-mediated inhibition of redox activity (MTT reduction) is not an indicator of astroglial degeneration. NeuroReport 7 (1996) 2026-2030
36. Robertson A., Karp W., and Brodersen R. Bilirubin displacing effects of drugs used in neonatology. Acta Paediatr. Scand. 80 (1991) 1119-1127
37. Rodrigues C.M., Sola S., Brites D., and Moura J.J. Perturbation of cell membrane dynamics is an early event during bilirubin-induced apoptosis. Hepatology 34 (2001) 273A
38. Rodrigues C.M.P., Sola S., and Brites D. Bilirubin induces apoptosis via the mitochondrial pathway in developing rat brain neurons. Hepatology 35 (2002) 1186-1195
39. Rootwelt T., Dunn M., Yudkoff M., Itoh T., Almaas R., and Pleasure D. Hypoxic cell death in human NT2-N neurons: Involvement of NMDA and non-NMDA glutamate receptors. J. Neurochem. 71 (1998) 1544-1553
40. Seubert J.M., Darmon A.J., El Kadi A.O.S., D'Souza S.J.A., and Bend J.R. Apoptosis in murine hepatoma Hepa 1c1c7 wild-type, C12, and C4 cells mediated by bilirubin. Mol. Pharmacol. 62 (2002) 257-264
41. Shapiro S.M. Acute brain-stem auditory evoked-potential abnormalities in jaundiced Gunn-rats given sulfonamide. Pediatr. Res. 23 (1988) 306-310
42. Shapiro S.M. Reversible brain-stem auditory-evoked potential abnormalities in jaundiced Gunn-rats given sulfonamide. Pediatr. Res. 34 (1993) 629-633
43. Shearman M.S., Hawtin S.R., and Tailor V.J. The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (Mtt) reduction is specifically inhibited by beta-amyloid peptides. J. Neurochem. 65 (1995) 218-227
44. Silva R.F.M., Mata L.M., Gulbenkian S., and Brites D. Endocytosis in rat cultured astrocytes is inhibited by unconjugated bilirubin. Neurochem. Res. 26 (2001) 793-800
45. Soorani-Lunsing I., Woltil H.A., and Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain?. Pediatr. Res. 50 (2001) 701-705
46. Stefanis L. Caspase-dependent and -independent neuronal death: two distinct pathways to neuronal injury. Neuroscientist 11 (2005) 50-62
47. Stefanis L., Park D.S., Yan C.Y.I., Farinelli S.E., Troy C.M., Shelanski M.L., and Greene L.A. Induction of CPP32-like activity in PC12 cells by withdrawal of trophic support-dissociation from apoptosis. J. Biol. Chem. 271 (1996) 30663-30671
48. Susin S.A., Daugas E., Ravagnan L., Samejima K., Zamzami N., Loeffler M., Costantini P., Ferri K.F., Irinopoulou T., Prevost M.C., Brothers G., Mak T.W., Penninger J., Earnshaw W.C., and Kroemer G. Two distinct pathways leading to nuclear apoptosis. J. Exp. Med. 192 (2000) 571-579
49. Vazquez J., Garciacalvo M., Valdivieso F., Mayor F., and Mayor F. Interaction of bilirubin with the synaptosomal plasma-membrane. J. Biol. Chem. 263 (1988) 1255-1265
50. Volbracht C., Leist M., Kolb S.A., and Nicotera P. Apoptosis in caspase-inhibited neurons. Mol. Med. 7 (2001) 36-48
51. Volpe J.J. Bilirubin and brain injury. Neurology of the Newborn (2003), W.B. Saunders Company, Philadelphia 521-546
52. Warr O., Mort D., and Attwell D. Bilirubin does not modulate ionotropic glutamate receptors or glutamate transporters. Brain Res. 879 (2000) 13-16
53. 2. Pediatr. Res. 34 (1993) 6-9